KATLYN BEIRING: Open Payments
NPI 1790472462 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,335 in 69 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $1,335
Food & beverage: $1,335
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 12 | $197 |
| ABBVIE INC. | 5 | $115 |
| TG Therapeutics, Inc. | 5 | $112 |
| Alexion Pharmaceuticals, Inc. | 4 | $84 |
| Tanabe Pharma America, Inc. | 4 | $77 |
| Mallinckrodt Hospital Products Inc. | 2 | $67 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| PFIZER INC. | 3 | $58 |
| UCB, Inc. | 3 | $52 |
| Neurocrine BioSciences, Inc. | 3 | $51 |
Products named: Ocrevus Zunovo, BOTOX, BRIUMVI, ULTOMIRIS, Radicava, ACTHAR, KESIMPTA, INGREZZA.
Industry payments across NY — which companies pay providers there.
